Epstein–Barr virus (EBV) is associated with various epithelial malignancies such as nasopharyngeal carcinoma and gastric carcinoma, and causes oral hairy leukoplakia, a productive EBV infection of the differentiated epithelium of the tongue. However, it is not clear by what mechanism EBV infects epithelial cells. We generated a recombinant EBV that expresses enhanced green fluorescent protein in order to monitor EBV entrance into epithelial cells quickly and quantitatively. Using this monitoring system, we examined the roles of gp350 and gp25 in EBV infection of epithelial cells by utilizing soluble forms of the gp350 and gp25 proteins. EBV infection of three of four examined epithelial cell lines, 293, NU-GC-3 and Lovo, was almost completely blocked by pretreatment of cells with a soluble form of gp350 (designated gp350Ig), and this blockage was dependent on the CD21-binding region of gp350. On the other hand, infection of the other epithelial cell line, AGS, was not inhibited at all by pretreatment with gp350Ig. Moreover, we found that a soluble form of gp25 (designated gp25Ig) preferentially bound to epithelial cells rather than B cells, and pretreatment of cells with gp25Ig substantially blocked EBV infection of some epithelial cells. These results indicate the existence of two distinct pathways in EBV infection of epithelial cells, a gp350-dependent pathway and a gp350-independent pathway, and that gp25 can play a role in the infection of some epithelial cells.
AkiyamaS.,
AmoH.,
WatanabeT.,
MatsuyamaM.,
SakamotoJ.,
ImaizumiM.,
IchihashiH.,
KondoT.,
TakagiH.1988; Characteristics of three human gastric cancer cell lines, NU-GC-2, NU-GC-3 and NU-GC-4. Japanese Journal of Surgery 18:438–446
BarrancoS. C.,
TownsendC. M.Jr,
CasartelliC.,
MacikB. G.,
BurgerN. L.,
BoerwinkleW. R.,
GourleyW. K.1983; Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Research 43:1703–1709
DrewinkoB.,
RomsdahlM. M.,
YangL. Y.,
AhearnM. J.,
TrujilloJ. M.1976; Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Research 36:467–475
FingerothJ. D.,
WeisJ. J.,
TedderT. F.,
StromingerJ. L.,
BiroP. A.,
FearonD. T.1984; Epstein–Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proceedings of the National Academy of Sciences, USA 81:4510–4514
FingerothJ. D.,
DiamondM. E.,
SageD. R.,
HaymanJ.,
YatesJ. L.1999; CD21-dependent infection of an epithelial cell line, 293, by Epstein–Barr virus. Journal of Virology 73:2115–2125
FradeR.,
BarelM.,
Ehlin-HenrikssonB.,
KleinG.1985; gp140, the C3d receptor of human B lymphocytes, is also the Epstein–Barr virus receptor. Proceedings of the National Academy of Sciences, USA 82:1490–1493
GrahamF. L.,
SmileyJ.,
RussellW. C.,
NairnR.1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36:59–74
GreenspanJ. S.,
GreenspanD.,
LennetteE. T.,
AbramsD. I.,
ConantM. A.,
PetersenV.,
FreeseU. K.1985; Replication of Epstein–Barr virus within the epithelial cells of oral ‘hairy’ leukoplakia, an AIDS-associated lesion. New England Journal of Medicine 313:1564–1571
HaddadR. S.,
Hutt-FletcherL. M.1989; Depletion of glycoprotein gp85 from virosomes made with Epstein–Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. Journal of Virology 63:4998–5005
ImaiS.,
KoizumiS.,
SugiuraM.,
TokunagaM.,
UemuraY.,
YamamotoN.,
TanakaS.,
SatoE.,
OsatoT.1994; Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein–Barr virus latent infection protein. Proceedings of the National Academy of Sciences, USA 91:9131–9135
ImaiS.,
NishikawaJ.,
TakadaK.1998; Cell-to-cell contact as an efficient mode of Epstein–Barr virus infection of diverse human epithelial cells. Journal of Virology 72:4371–4378
JanzA.,
OezelM.,
KurzederC.,
MautnerJ.,
PichD.,
KostM.,
HammerschmidtW.,
DelecluseH.-J.2000; Infection of Epstein–Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands. Journal of Virology 74:10142–10152
KieffE.1996; Epstein–Barr virus and its replication. In Fields Virology pp 2343–2396 Edited by
FieldsB. N.,
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott–Raven;
LiQ.,
TurkS. M.,
Hutt-FletcherL. M.1995; The Epstein–Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. Journal of Virology 69:3987–3994
LiQ.,
SpriggsM. K.,
KovatsS.,
TurkS. M.,
ComeauM. R.,
NepomB.,
Hutt-FletcherL. M.1997; Epstein–Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. Journal of Virology 71:4657–4662
LinsleyP. S.,
BradyW.,
GrosmaireL.,
AruffoA.,
DamleN. K.,
LedbetterJ. A.1991a; Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. Journal of Experimental Medicine 173:721–730
LinsleyP. S.,
BradyW.,
UrnesM.,
GrosmaireL. S.,
DamleN. K.,
LedbetterJ. A.1991b; CTLA-4 is a second receptor for the B cell activation antigen B7. Journal of Experimental Medicine 174:561–569
MillerN.,
Hutt-FletcherL. M.1988; A monoclonal antibody to glycoprotein gp85 inhibits fusion but not attachment of Epstein–Barr virus. Journal of Virology 62:2366–2372
MolesworthS. J.,
LakeC. M.,
BorzaC. M.,
TurkS. M.,
Hutt-FletcherL. M.2000; Epstein–Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells. Journal of Virology 74:6324–6332
NemerowG. R.,
MoldC.,
SchwendV. K.,
TollefsonV.,
CooperN. R.1987; Identification of gp350 as the viral glycoprotein mediating attachment of Epstein–Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. Journal of Virology 61:1416–1420
NemerowG. R.,
HoughtenR. A.,
MooreM. D.,
CooperN. R.1989; Identification of an epitope in the major envelope protein of Epstein–Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell 56:369–377
NishikawaJ.,
ImaiS.,
OdaT.,
KojimaT.,
OkitaK.,
TakadaK.1999; Epstein–Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. Journal of Virology 73:1286–1292
ParkerB. D.,
BankierA. T.,
SatchwellS. C.,
BarrellB. G.,
FarrellP. J.1990; Sequence and transcription of Raji Epstein–Barr virus DNA spanning the B95-8 deletion region. Virology 179:339–346
RickinsonA. B.,
KieffE.1996; Epstein–Barr virus. In Fields Virology pp 2397–2446 Edited by
FieldsB. N.,
KnipeD. M.,
HowleyP. M.
Philadelphia: Lippincott–Raven;
ShimizuN.,
Tanabe-TochikuraA.,
KuroiwaY.,
TakadaK.1994; Isolation of Epstein–Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt’s lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. Journal of Virology 68:6069–6073
SpriggsM. K.,
ArmitageR. J.,
ComeauM. R.,
StrockbineL.,
FarrahT.,
MacduffB.,
UlrichD.,
AldersonM. R.,
MüllbergJ.,
CohenJ. I.1996; The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA- DR β chain and inhibits antigen presentation. Journal of Virology 70:5557–5563
TakadaK.1984; Cross-linking of cell surface immunoglobulins induces Epstein–Barr virus in Burkitt lymphoma lines. International Journal of Cancer 33:27–32
TakadaK.,
HorinouchiK.,
OnoY.,
AyaT.,
OsatoT.,
TakahashiM.,
HayasakaS.1991; An Epstein–Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:147–156
WangX.,
Hutt-FletcherL. M.1998; Epstein–Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. Journal of Virology 72:158–163
WangX.,
KenyonW. J.,
LiQ.,
MüllbergJ.,
Hutt-FletcherL. M.1998; Epstein–Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. Journal of Virology 72:5552–5558
YamadaA.,
MurakamiM.,
IjimaK.,
YagitaH.,
OkumuraK.,
KomatsuS.,
UedeT.1996; Long-term acceptance of major histocompatibility complex-mismatched cardiac allograft induced by a low dose of CTLA4IgM plus FK506. Microbiology and Immunology 40:513–518
YoshiyamaH.,
ShimizuN.,
TakadaK.1995; Persistent Epstein–Barr virus infection in a human T-cell line: unique program of latent virus expression. EMBO Journal 14:3706–3711
YoshiyamaH.,
ImaiS.,
ShimizuN.,
TakadaK.1997; Epstein–Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. Journal of Virology 71:5688–5691